Relapsing epidemic typhus (Brill-Zinsser disease) in China - 30/04/24
Doi : 10.1016/j.jinf.2024.106152
Miao Lu a, 1, Shizhe Chen b, 1, Huafeng Li b, Wen Wang a, Kun Li a, ⁎ 
a National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping District, 102206 Beijing, China
b Yingkou Center for Disease Control and Prevention, 115000 Yingkou, Liaoning Province, China
⁎Correspondence to: National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping Liuzi 5, 102206 Beijing, China.National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and PreventionChangping Liuzi 5Beijing102206China
Le texte complet de cet article est disponible en PDF.
Plan
© 2024
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 5
Article 106152- mai 2024 Retour au numéro
Article précédent
- Novel antivirals for severe enterovirus infection in immunocompromised hosts; A case series
- Andrea Meinhardt, Liam Reilly, Marios Kaliakatsos, Khaled Abdel-Aziz, Sondus Alsharidah, Istvan Bodi, Claire Booth, Kritika Chetty, Jennifer Evans, Laura Ferreras-Antolín, Susannah Froude, Clare M. Galtrey, Suba Guruprasad, Robert D. Hadden, Jane Hassell, Heikki Hyöty, Alexandra Y. Kreins, Jutta E. Laiho, David M. Lowe, Michael P. Lunn, Kshitij Mankad, Siske Struik, Elizabeth Whittaker, Austen Worth, Patrick Yong, Liqun Zhang, Judith Breuer, Seilesh Kadambari
- Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC)—The hunt for effective treatments
- Norman B. Gaylis, Otto O. Yang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?